Navigation Links
Finesse Introduces TruBio(TM) IOQ
Date:12/4/2007

SANTA CLARA, Calif., Dec. 4 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the general release of its TruBio(TM) IOQ package. TruBio(TM) IOQ is designed to take the guesswork out of validation and to complement the fully configurable TruBio(TM) operating system (TruBio(TM) OS).

Traditional validation of control systems can be expensive and time consuming, especially when new documents are created by external validation service contractors. The TruBio(TM) IOQ package provides all of the protocols needed to validate the maximum process configuration of a specific bioreactor type. By simply choosing the relevant sections and following the pre-written test procedures, end users can complete their installation and operational qualification.

Project managers utilizing TruBio(TM) IOQ can save valuable project time by eliminating the need to develop validation protocols and by minimizing the validation efforts traditionally found in implementing a new control system. With TruBio(TM) IOQ, customers can quickly validate TruBio(TM) OS functionality, minimize down time and improve predictability of the installation schedule.

Upon completing TruBio(TM) IOQ, users will establish documented evidence assuring that TruBio(TM) OS meets all user requirements and design specifications. TruBio(TM) IOQ provides objective evidence that TruBio(TM) OS performs consistently and accurately per its intended use in the bioprocess application. TruBio(TM) IOQ follows and incorporates established GAMP4 guidelines to ensure that TruBio(TM) OS is compliant with FDA's Title 21 Code of Federal Regulations Parts 11, 210 and 211. TruBio(TM) IOQ also ensures that the TruBio(TM) OS will function as specified in cGMP and cGLP environments.

"The days of long and expensive validation are over. TruBio(TM) IOQ will streamline Installation and Operational Qualifications and at the same time be affordable!" says Yeng Vang, validation manager at Finesse.

About Finesse

California based Finesse leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
2. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
5. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
6. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
7. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
8. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... evaluation of multiple immunoassay-based threat detection technologies by researchers from the Pacific ... biosensor threat detection technology was found to have the best level of ...
(Date:2/23/2017)... ... ... Today, researchers can fast-track sample collection and analysis for ... or SNPs of interest) using one, easy-to-collect saliva sample. With the addition of ... and other relevant biomarkers can be extensively studied through a non-invasive sample type. ...
(Date:2/23/2017)... , Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), ... medical conditions, today announced that Linda Marbán, Ph.D, president and ... investor conferences: Cowen and Company 37th ... am ET Boston, MA ... 9:00 am PT (12:00 pm ET) Dana Point, ...
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
Breaking Biology Technology:
(Date:2/3/2017)... 2017 A new independent identity strategy consultancy ... (IdSP) . Designed to fill a critical niche in ... founding partners Mark Crego and Janice ... in identity expertise that span federal governments, the 9/11 ... Crego-Kephart combined expertise has a common theme born from ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
(Date:1/30/2017)... 2017   Invitae Corporation (NYSE: ... companies, today announced that it will report its fourth ... guidance on Monday, February 13, 2017, and Invitae,s management ... 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... review financial results, guidance, and recent developments and will ...
Breaking Biology News(10 mins):